{"id":"W2606976048","doi":"10.1016/j.eururo.2017.03.037","title":"Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"ca_institutions":"Regional Municipality of Durham; Lakeridge Health","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Internal medicine; Carcinoma; Oncology; Kidney cancer; Urology; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102767,0.0003730972,0.0005127859,0.0002207622,0.0001188568,0.00002609792,0.0001808495,0.00006768015,0.00003682925],"category_scores_gemma":[0.00001531243,0.0002326101,0.00004978923,0.00009575843,0.0001833035,0.000110087,0.00007955501,0.000212021,0.00008981278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002992751,"about_ca_system_score_gemma":0.00008063563,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001174195,"about_ca_topic_score_gemma":0.0002047587,"domain_scores_codex":[0.9980472,0.0002403681,0.0003243794,0.0006418992,0.0002292416,0.0005169481],"domain_scores_gemma":[0.9985604,0.00002530985,0.0002695245,0.0009019976,0.00007193418,0.00017081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00894799,0.001326568,0.9700795,0.0000239937,0.00003281411,0.00499825,0.0002996069,0.0000394977,0.0007680781,0.000003179752,0.00001690275,0.01346359],"study_design_scores_gemma":[0.02974506,0.02070348,0.9435661,0.00005096887,0.0001101456,0.00005292867,0.00001536008,0.00003464702,0.004949009,0.000001829216,0.0005661006,0.0002043196],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9574478,0.0001678377,0.000002033373,0.0002038973,0.00003384957,0.001097796,0.00001097879,0.00004122451,0.04099454],"genre_scores_gemma":[0.9981943,0.00001212746,0.0004893923,0.00006275868,0.00003604396,0.00005391415,0.000139424,0.00008189665,0.0009301453],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04074646,"threshold_uncertainty_score":0.9485564,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009601757548408387,"score_gpt":0.2332804327322882,"score_spread":0.2236786751838798,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}